HF and Transplantation to focus on day-to-day care of patients, progess in field

Young, James B.
July 2008
Cardiology Today;Jul2008, Vol. 11 Issue 7, p40
The author details some of the advances in the field of heart failure (HF) and cardiac transplantation. He describes some of the progress in the understanding of the pathophysiology, epidemiology, demographics and treatments of HF. He cites, however, some of the disappointments in researches on treating the HF syndrome. The author also emphasizes the reason "Cardiology Today" will cover the field of HF and cardiac transplantation.


Related Articles

  • The Usefulness of Chronic Heart Failure Treatments in Chronic Cardiac Graft Failure. Najam, Osman; Yonan, Nizar; Williams, Simon G.; Shaw, Steven M. // Cardiovascular Therapeutics;Feb2010, Vol. 28 Issue 1, p48 

    Following cardiac transplantation, registry data has demonstrated a gradual improvement in survival over the last several decades, which is testament to continual improvement in aftercare strategy. However, a significant number of patients will eventually develop a new syndrome of chronic heart...

  • Anemia in Chronic Heart Failure - Clinical and Prognostic Significance. Karhausen, T.; Anker, Stefan D.; Doehner, W. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Oct2005, Vol. 3 Issue 4, p297 

    Anemia is a common finding in chronic heart failure (CHF). Anemia develops due to CHF, but is also known to cause heart failure. Patients with CHF are limited by exercise capacity and fatigue. Low hemoglobin concentration can account for both and may substantially contribute to the symptoms of...

  • The Mutations Associated with Dilated Cardiomyopathy. Parvari, Ruti; Levitas, Aviva // Biotechnology Research International;2012, p1 

    Cardiomyopathy is an important cause of heart failure and a major indication for heart transplantation in children and adults. This paper describes the state of the genetic knowledge of dilated cardiomyopathy (DCM). The identification of the causing mutation is important since presymptomatic...

  • Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom. Cushing, Kelly; Kushnir, Vladimir // Digestive Diseases & Sciences;Jun2016, Vol. 61 Issue 6, p1440 

    Background: Left ventricular assist devices (LVADs) are an increasingly prevalent form of mechanical support for patients with end-stage heart failure. These devices can be implanted both as a bridge to transplant and as definitive/destination therapy. Gastrointestinal (GI) bleeding...

  • Transplant coronary heart disease: challenges and solutions. Jentzer, Jacob C.; Hickey, Gavin W.; Khandhar, Sameer J. // Transplant Research & Risk Management;2014, Vol. 6, p117 

    Cardiac allograft vasculopathy (CAV) remains one of the leading causes of death and graft failure after heart transplantation. A variety of causes, including donor heart characteristics, recipient risk factors, and immune-mediated influences, are associated with developing CAV. In this review,...

  • Renal Impairment an Impediment to Heart Transplantation? Rafat, C├ędric; Hertig, Alexandre; Rondeau, Eric // Iranian Journal of Kidney Diseases;Mar2015, Vol. 9 Issue 2, p77 

    Chronic kidney disease and chronic heart failure are now recognized as closely intertwined entities. The noxious interactions between the heart and kidney systems as part of the so-called cardiorenal syndrome is a matter of great concern for heart transplant candidates. Not only is chronic...

  • Medical and Ventilatory Treatment of Acute Heart Failure: New Insights. Hodt, Anders; Steine, Kjetil; Atar, Dan // Cardiology;2006, Vol. 106 Issue 1, p1 

    Background: The traditional medical treatment of acute heart failure (AHF) has remained unchanged for many years. It has been based on oxygen supplementation and mechanical ventilatory support as well as the administration of morphine, diuretics, nitrates and inotropic agents. In 2005 the...

  • Heart failure with preserved ejection fraction. Gladden, James; Linke, Wolfgang; Redfield, Margaret // Pflugers Archiv European Journal of Physiology;Jun2014, Vol. 466 Issue 6, p1037 

    As part of this series devoted to heart failure (HF), we review the epidemiology, diagnosis, pathophysiology, and treatment of HF with preserved ejection fraction (HFpEF). Gaps in knowledge and needed future research are discussed.

  • Sildenafil and Exercise Capacity in Heart Failure. Guazzi, Marco; Bandera, Francesco; Forfia, Paul; Redfield, Margaret M.; Borlaug, Barry A. // JAMA: Journal of the American Medical Association;7/24/2013, Vol. 310 Issue 4, p432 

    A letter to the editor and a response from the author of the article "Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment" that was published in the earlier edition of the journal is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics